Who we are

The SIRIC label

The SIRIC label is a flagship program of the cancer plan aimed at identifying and supporting "comprehensive cancer centers" in France

In order to reach this objective the SIRICs have a triple mission: integration, structuring, and use of research results :

• Mission 1: Elaborate and conduct a certain number of integrated research programs within a national and international collaborative network. The ultimate objective is to reduce the incidence of cancer and its mortality and to improve patient care.
• Mission 2: Establish the necessary infrastructure and resources to conduct research responding to the criteria of excellence, innovation, integration, multidisciplinarity and transfert to the clinic (technological platforms, research support structures, protected time for clinicians, attractiveness for new researchers etc.)
• Mission 3: Ensure the application and dissemination of results and acquired knowledge

Find out more about the network of SIRICs in France

The SIRIC label at Institut Curie

The Institut Curie was one of the first centers to receive the label, along with the Léon Bérard Center, in 2011. The label will be renewed in 2018 and 2022.

Find out more about SIRIC-Curie's previous scientific programs in 2011 and 2018

Our organisation

To develop these missions we rely on a steering committee, an international scientific board and a number of working groups. Details of the organization chart :

Our international scientific advisory board

This board made up of international experts advises the SIRIC on strategic orientation.

SIRIC funding

The SIRICs are jointly funded by the French National Cancer Institute (INCa), the Ministry of Health (DGOS) and the French National Institute for Medical Research (Inserm) on behalf of the Alliance for Life Sciences and Health (Aviesan).